中国现代医生2024，Vol.62Issue(13)：51-55,5.DOI:10.3969/j.issn.1673-9701.2024.13.014
中国医药科技型创新企业支持政策量化分析
Quantitative analysis of the supporting policies for pharmaceutical science and technology innovative enterprises in China
赵倩倩 1陈柯羽 2杨珑平 1刘泽坤 1杨俊涛 3李青3
作者信息
- 1. 中国医学科学院/北京协和医学院卫生健康管理政策学院,北京 100730
- 2. 中国医学科学院/北京协和医学院,北京 100730
- 3. 中国医学科学院/北京协和医学院卫生健康管理政策学院,北京 100730||中国医学科学院/北京协和医学院,北京 100730
- 折叠
摘要
Abstract
Objective Based on the framework of"quantitative analysis of supporting policies",this study focuses on the formulation and implementation of supporting policies for pharmaceutical science and technology innovative enterprises in China,so as to provide a certain reference for the implementation and improvement of policies for pharmaceutical science and technology innovative enterprises in China.Methods This study used Roy Rothwell and Walter Zegveld's innovative policy tools as the basis for analysis,and combined with the dimension of policy type,the policy was quantitatively analyzed.Results A total of 47 effective policy documents were selected,including 22 issued by the state and 25 issued by Beijing municipal government.A total of 104 policy instruments were included through the dismantling of policy provisions.Specifically,environment-based policy tools accounted for the highest proportion(60.58%),while demand-based and supply-based policy tools were relatively few.From the perspective of policy types,there were more planning policy documents(25 articles),while there were relatively few specific implementation policies(22 articles).Conclusion It is necessary to focus on optimizing the formulation stage of support policies and improving the use of supply-oriented and demand-oriented policy tools to better meet the needs of pharmaceutical science and technology innovative enterprises.关键词
医药科技型创新企业/创新发展/政策工具/政策制定/量化分析Key words
Pharmaceutical science and technology innovative enterprises/Innovation and development/Policy tools/Policy formulation/Quantitative analysis分类
医药卫生引用本文复制引用
赵倩倩,陈柯羽,杨珑平,刘泽坤,杨俊涛,李青..中国医药科技型创新企业支持政策量化分析[J].中国现代医生,2024,62(13):51-55,5.
